Skip to main content

Table 3 Predictors of all-cause mortality in older patients with diabetes with and without chronic kidney disease

From: Effect of frailty, physical performance, and chronic kidney disease on mortality in older patients with diabetes : a retrospective longitudinal cohort study

 

DM without CKD

DM with CKD

Simple model 1

Multiple model 1

Simple model 2

Multiple model 2

Multiple model 3

Multiple model 4

 HR (95% CI)

HR

(95% CI)

HR

(95% CI)

HR

(95% CI)

HR

(95% CI)

HR

(95% CI)

Age

1.00 (0.94–1.06)

  

1.03 (0.99–1.06)

      

Male vs. Female

1.05 (0.46–2.39)

  

0.97 (0.60–1.58)

      

CCI

1.44 (1.09–1.90)*

1.28 (0.89–1.83)

1.08 (0.88–1.32)

      

Comprehensive geriatric assessment

        

 MNA-SF

0.86 (0.77–0.96)**

1.03 (0.83–1.27)

0.85 (0.80–0.91)**

1.00 (0.76–1.31)

0.97 (0.88–1.07)

0.94 (0.86–1.04)

 RFI ≥ 0.313

5.28 (2.47–11.26)**

1.90 (0.54–6.64)

5.92 (3.44–10.18)**

4.01 (0.96–16.78)

4.77 (1.98–11.49)*

5.34 (2.23–12.80)**

 TUG test

1.00 (0.93–1.06)

  

1.01 (0.99–1.03)

      

 TUG test ≥ 21 s

1.05 (0.21–5.22)

  

2.50 (1.22–5.13)*

2.98 (0.84–10.51)

    

 Prolonged 6 MW

0.02 (0.00-53.10)

  

0.03 (0.00-9.26)

      

 Poor HGS

2.82 (0.70-11.31)

  

2.67 (1.12–6.37)*

1.17 (0.31–4.42)

    

Laboratory data

          

 HgB

0.85 (0.71–1.03)

  

0.68 (0.60–0.76)**

  

0.76 (0.65–0.89)**

0.75 (0.64–0.87)**

 Albumin

0.23 (0.13–0.43)**

0.19 (0.07–0.53)**

0.40 (0.31–0.52)**

  

0.67 (0.40–1.10)

  

 Fasting glucose

1.01 (1.003–1.01)**

1.004 (1.0001-1.01)*

1.00 (1.00–1.00)

      

 eGFR

0.98 (0.97-1.00)*

1.00 (0.99–1.02)

0.98 (0.97–0.99)**

  

0.99 (0.98–0.999)*

0.99 (0.98-1.00)

 Proteinuria

0.99 (0.51–1.90)

  

1.15 (1.04–1.26)**

  

0.96 (0.84–1.09)

1.00 (0.88–1.13)

  1. *P < 0.05; **P < 0.01; Multiple model 1 in DM without CKD: The Cox proportional hazard model was used to evaluate the association of all-cause mortality with multivariate analysis among the Charlson Comorbidity Index (CCI), mini-nutritional assessment-short form (MNA-SF), Rockwood frailty index (RFI) ≥ 0.313, serum albumin, glucose, and eGFR. Multiple model 2 in DM with CKD: The Cox proportional hazard model was used to evaluate the association of all-cause mortality with multivariate analysis among MNA-SF, RFI ≥ 0.313, timed up and go (TUG) test ≥ 21 s, and abnormal handgrip strength (HGS). Multiple model 3 in DM with CKD: The Cox proportional hazard model was used to evaluate the association of all-cause mortality with multivariate analysis among MNA-SF, RFI ≥ 0.313, serum HgB, albumin, eGFR, and proteinuria. Multiple model 4 in DM with CKD: The Cox proportional hazard model was used to evaluate the association of all-cause mortality with multivariate analysis among MNA-SF, RFI ≥ 0.313, serum HgB, eGFR, and proteinuria. Prolonged 6 MW (F > 17.51/M > 8.95 s); Poor HGS (F < 10.57/M < 20.4 kg). 6 MW 6-meter walking test, HGS handgrip strength, eGFR estimated glomerular filtration rate, eGFR calculated by using modified Modification diet of renal disease (MDRD) formula, was utilized to evaluate renal function.